Tokio Marine Asset Management Co. Ltd. Purchases Shares of 15,361 Chemed Co. (NYSE:CHE)

Tokio Marine Asset Management Co. Ltd. acquired a new position in Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 15,361 shares of the company's stock, valued at approximately $8,138,000. Tokio Marine Asset Management Co. Ltd. owned about 0.10% of Chemed as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new stake in shares of Chemed in the third quarter worth $437,150,000. FMR LLC raised its holdings in Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after buying an additional 45,917 shares during the last quarter. Thrivent Financial for Lutherans lifted its stake in shares of Chemed by 25.3% in the third quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company's stock worth $87,752,000 after buying an additional 29,445 shares in the last quarter. Aureus Asset Management LLC grew its holdings in shares of Chemed by 3,147.2% during the third quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock valued at $17,993,000 after buying an additional 29,017 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its position in shares of Chemed by 143.5% during the third quarter. Allspring Global Investments Holdings LLC now owns 42,267 shares of the company's stock valued at $25,401,000 after acquiring an additional 24,912 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Chemed Price Performance

Chemed stock traded up $5.89 during mid-day trading on Wednesday, reaching $563.56. 25,390 shares of the stock traded hands, compared to its average volume of 89,790. The stock has a market capitalization of $8.48 billion, a PE ratio of 28.51, a price-to-earnings-growth ratio of 2.19 and a beta of 0.48. The business's 50-day moving average is $544.14 and its 200-day moving average is $564.46. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend was Monday, November 18th. Chemed's payout ratio is 10.11%.

Wall Street Analyst Weigh In

CHE has been the topic of a number of research analyst reports. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada lowered their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company's stock, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Spencer S. Lee sold 732 shares of the firm's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.